Drug Target Review2024-08-01T12:00:46
Organoids with SMA-pathology uncovered key findings about the disease, which could be utilised to develop new therapeutic options.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2025-05-28T14:00:00
Sponsored by Eurofins DiscoverX
2023-03-20T13:41:33
Sponsored by Bio-Techne
2025-08-05T13:42:00
Sponsored by ICON plc., Drug Target Review
2026-08-10T08:58:00
Author Abhishek Jha
2023-03-02T13:57:58
Sponsored by Cell Signaling Technology
Site powered by Webvision Cloud